Document is current
Any future updates will be listed below
-
Authors
Zhou, Wenqiang
Wang, Qingfeng
Nie, Wenjuan
Shi, Wenhui
Yang, Yang
Qi, Wenjie
Lu, Yu
Chu, Naihui
-
Funding
Funding for this research was provided by:
National Key Clinical Specialist Construction Programs
High-level Public Health Technology Talent Construction Project (Academic Leader-02-29)
National Key Research and Development Program (2024YFC2311203)
Special Project of Guangzhou National Laboratory for 2024- Short Term Treatment of Tuberculosis (GZNL2024A01030)
Global Tuberculosis Drug Research and Development Alliance Cooperation Project of China Anti-TB Association (CATA/TBA-20210310HQ7)
Beijing Clinical Medicine Development Special Project "Sailing 3.0" (ZLRK202331)
Beijing Municipal Health Commission Research Ward Excellent Clinical Research Program (BRWEP2024W042160109)
- License Information
-
More Information
Article History
Received: 5 November 2025
Accepted: 9 February 2026
First Online: 14 February 2026
Declarations
:
: This retrospective study was approved by the Institutional Review Board of Beijing Chest Hospital (protocol no. YJS-2020-012; approved on September 16, 2020) and was conducted in accordance with the Declaration of Helsinki. The ethics committee granted a waiver of individual informed consent as the research involved no more than minimal risk and used existing archived bacterial isolates and completely anonymized clinical data.
: Not applicable.
: The authors declare no competing interests.
